DocGo Stock

DocGo EBITDA per Employee

The EBITDA per Employee of DocGo (DCGO) as of Aug 8, 2026 is 26,127.55 USD. In the previous year, EBITDA per Employee was 18,612.19 USD — a change of 40.38% (higher).

EBITDA per Employee

26,127.55USD

YoY

40.38%

Last updated:

EBITDA per Employee of DocGo is 2026 26,127.55 USD. EBITDA per Employee of DocGo was 2025 18,612.19 USD. It decreases by 40.38% higher compared to the previous year.
Access this data via the Eulerpool API

DocGo Stock analysis

What does DocGo do? The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DocGo stock

EBITDA per Employee of DocGo is 26,127.55 USD in 2026.

EBITDA per Employee of DocGo changed from 18,612.19 USD to 26,127.55 USD, representing a 40.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee DocGo since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's DocGo historically and in real time.

Access this data via the Eulerpool API

Workforce — DocGo

All Key Metrics — DocGo